How Mark Cuban is Turning the Prescription Drug Industry Upside Down

When Mark Cuban enters an industry, he typically disrupts it in one way or another. And that’s precisely what it appears he has done once again, though this time in the healthcare space. His Cost Plus Drug Company has turned the industry on its head and introduced transparency to the previously opaque area of prescription drug prices.

“We started [Mark Cuban Cost Plus Drug Company] with the goal of being the low-cost provider for generic drugs,” Cuban told MarketScale. 

The company’s website features a chart displaying the stark difference in the retail price of these drugs versus what consumers pay through their platform. But perhaps the most striking thing about the Cost Plus Drug Company is the clarity of the pricing structure. Leadership has been vocal, on the site and on social media, about how Cost Plus Drugs gets to its final prices in an effort to set a new standard for patient-focused transparency.

For example, every drug is priced with the same markups: a 15% markup supports operations, a $3 charge covers pharmacy labor, and then the usual fixed and variable costs of shipping round out the total. Some savings are minimal; a 60-count of 20mg Fluoxetine, the generic alternative for depression and OCD treatment drug Prozac, costs $4.80 for a Cost Plus Drugs customer, compared to the retail price of $43.80.

Some savings are so stark that they warrant a double take. For a 30-count of 400mg Imatinib, the generic version of leukemia-treatment drug Gleevec, Cost Plus Drugs customers pay $47.50, compared to the retail price of $9,657.40, an enormous difference in cost.

“We will do whatever it takes to get affordable pharmaceuticals to patients,” said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug. “The markup on potentially lifesaving drugs that people depend on is a problem that can’t be ignored. It is imperative that we take action and help expand access to these medications for those who need them most.”

With this cost savings business model, underinsured or uninsured patients who’d be paying close to or full price would see the most immediate benefits. Even insured patients though, according to the company’s site, would pay “less than what you would pay when using your insurance at a typical pharmacy.”

The cost of drugs in the United States has been a problem for some time, garnering attention from President Biden and putting a financial strain on many Americans. According to Kevin Stevenson, Director of Strategic Operations at Providence Healthcare Network in Waco, TX, affecting positive change in this side of the industry is critical, as for patients, it’s truly a life or death situation.

“People who don’t have insurance that are paying out of pocket, oftentimes they skip medications because they take food out of their family’s mouth,” Stevenson said.

The high-profile attention that Cuban’s company, as well as the issue at-large, is getting could be a sign of things to come for healthcare in the United States.

“I think we’re seeing people in healthcare now that are having that more entrepreneurial mindset, that are looking at problems and saying how can we look at it from a different viewpoint to try to solve this,” he said.

Stevenson admitted that change in healthcare can come slowly, but with sharks like Mark Cuban in the water, change could be coming sooner rather than later. 

Follow us on social media for the latest updates in B2B!

Image

Latest

sterile compounding
Sterile Compounding and Contamination Control with Abby Roth
March 11, 2025

In this episode of Exceeding Your Benchmark, host Michelle Dawn Mooney speaks with Abby Roth, founder of Pure Microbiology, about sterile compounding and contamination control. Abby shares her expertise in microbiology, sterile environments, and best practices in pharmaceutical compounding. The conversation begins with a distinction between traditional drug manufacturing and sterile compounding, highlighting the…

Read More
hearing test
Convenient Online Hearing Test from HearUSA Enhances Your Hearing Health Journey
March 11, 2025

Struggling to hear conversations could be more prevalent than you think. As a leader in hearing care, HearUSA offers an easy solution that you can manage from the comfort of your home: the HearUSA Online Hearing Test. Experience the Simplicity This quick, free, and convenient online test is designed to examine your hearing in…

Read More
Lessons from Gen Z: Why Marketers Need to Adapt to Current Digital Trends
Lessons from Gen Z: Why Marketers Need to Adapt to Current Digital Trends
March 7, 2025

On this episode of UGC for B2B, hosts Hunter Lopatin and Jamison Wheeler take over for a special Gen Z edition, breaking down why big brands struggle to embrace user-generated content (UGC) and how the next generation is reshaping the marketing landscape. As a former NCAA athlete and current B2B marketing professional, Jamison shares firsthand…

Read More
Stephanie Simon
Through the Storm with USMC Captain, Professional Boxer, and TrailBlazer, Stephanie Simon
March 7, 2025

Captain Stephanie Simon (USMC) is currently a professional boxer (2-0), a boxing instructor, and a Marine Corps reservist. She is the 2024 Olympic Trials Boxing Champion, 4x Elite National Boxing Champion, 3x National Collegiate Boxing Champion, and United States Marine Corps Boxing Hall of Famer. Stephanie Simon is originally from Atlanta, GA, grew up…

Read More